---
title: "VBIO.US (VBIO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VBIO.US/news.md"
symbol: "VBIO.US"
name: "VBIO.US"
parent: "https://longbridge.com/en/quote/VBIO.US.md"
datetime: "2026-06-13T18:31:27.215Z"
locales:
  - [en](https://longbridge.com/en/quote/VBIO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VBIO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VBIO.US/news.md)
---

# VBIO.US (VBIO.US) — Related News

### [Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures | VBIO Stock News](https://longbridge.com/en/news/289458996.md)
*2026-06-11T03:45:00.000Z*
> Valion Bio (NASDAQ: VBIO) confirmed that the U.S. House Armed Services Committee's FY27 NDAA report directs the Departme

### [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://longbridge.com/en/news/289379675.md)
*2026-06-10T21:05:55.000Z*
> In Wednesday's after-market session, several healthcare stocks saw significant movement. Gainers included HeartSciences 

### [VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME | VBIO Stock News](https://longbridge.com/en/news/286964504.md)
*2026-05-19T12:40:28.000Z*
> VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYND

### [Valion Bio Reports Q1 Results, Advances Entolimod Platform](https://longbridge.com/en/news/286477206.md)
*2026-05-14T22:33:28.000Z*
> Valion Bio (VBIO) reported its Q1 2026 results, marking its first full reporting period post-divestiture of its consumer

### [Valion Bio Q1 2026 Earnings Call: Complete Transcript](https://longbridge.com/en/news/286471126.md)
*2026-05-14T21:20:05.000Z*
> Valion Bio (NASDAQ:VBIO) held its Q1 2026 earnings call, discussing its transition from Tivic Health Systems and focus o

### [Valion Bio | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286466910.md)
*2026-05-14T20:51:40.000Z*
### [Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform | VBIO Stock News](https://longbridge.com/en/news/286465757.md)
*2026-05-14T12:31:00.000Z*
> Valion Bio's subsidiary, Velocity Bioworks, has secured an exclusive commercial license for LarmorBio's BioScan-NMR™ pla